Document Detail


Outcome of toxoplasmosis acquired during pregnancy following treatment in both pregnancy and early infancy.
MedLine Citation:
PMID:  17652934     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: Congenital toxoplasmosis is associated with clinical dilemmas as untreated infants may have a guarded prognosis and as treatment may induce severe side effects. The aim of this study was to investigate the outcome of infants born to mothers with toxoplasmosis acquired during pregnancy, following administration of appropriate regimens both during pregnancy and early infancy. STUDY DESIGN: All 35 infants, born to mothers with toxoplasmosis acquired during pregnancy, and referred to the major Neonatal Department in Crete, Greece, during the 7-year period 1997-2003 were included. All neonates were evaluated soon after birth and on a regular follow-up. RESULTS: Almost all mothers received spiramycin from diagnosis through labor and 2 received pyrimethamine and sulfadiazine. At birth, infants had IgG antibody titers ranging from 1/1,350 to 1/109,350. All infants initially received pyrimethamine, sulfadiazine and folinic acid but in only 4 cases treatment was continued beyond the second month of life. Transient neutropenia was commonly observed. A follow-up period of 1.2-8.2 years did not reveal any remarkable sequelae. CONCLUSIONS: Our findings suggest that effective treatment both during pregnancy and early infancy is safe and may contribute to a good outcome of infants born to mothers with toxoplasmosis acquired during pregnancy.
Authors:
Emmanouil Galanakis; Antonia Manoura; Maria Antoniou; Stavros Sifakis; Eftichia Korakaki; Eleftheria Hatzidaki; Dimitra Lambraki; Yiannis Tselentis; Christina Giannakopoulou
Related Documents :
18480714 - Effectiveness of the test of infant motor performance as an educational tool for mothers.
1301424 - Using relaxation with guided imagery to assist primiparas in achieving maternal role at...
20390524 - The origins of 12-month attachment: a microanalysis of 4-month mother-infant interaction.
23142784 - Community-acquired neonatal and infant sepsis in developing countries: efficacy of who'...
2109114 - Comparison of low, medium, and high carbohydrate formulas for nighttime enteral feeding...
11055634 - Effect of home and hospital delivery on long-term cognitive function.
Publication Detail:
Type:  Comparative Study; Journal Article     Date:  2007-07-24
Journal Detail:
Title:  Fetal diagnosis and therapy     Volume:  22     ISSN:  1421-9964     ISO Abbreviation:  Fetal. Diagn. Ther.     Publication Date:  2007  
Date Detail:
Created Date:  2007-10-29     Completed Date:  2007-12-20     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9107463     Medline TA:  Fetal Diagn Ther     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  444-8     Citation Subset:  IM    
Copyright Information:
Copyright 2007 S. Karger AG, Basel.
Affiliation:
Department of Neonatology, University Hospital of Heraklion, Heraklion, Greece. egalanak@med.uoc.gr
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Child
Child, Preschool
Female
Follow-Up Studies
Humans
Infant
Infant, Newborn
Male
Pregnancy
Pregnancy Complications, Parasitic / diagnosis,  therapy*
Spiramycin / therapeutic use
Toxoplasmosis / diagnosis,  therapy*
Toxoplasmosis, Congenital / diagnosis,  prevention & control
Treatment Outcome
Chemical
Reg. No./Substance:
8025-81-8/Spiramycin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Multiple true umbilical knots: a silent risk for intrauterine growth restriction with anomalous hemo...
Next Document:  Takayasu arteritis in pregnancy: safe management options in antenatal care. Case report.